These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35699869)

  • 1. Rivaroxaban After Transcatheter Aortic Valve Replacement: A Critical Appraisal of the GALILEO Trial.
    Sulzgruber P; Hammer A; Niessner A
    Cardiovasc Drugs Ther; 2023 Dec; 37(6):1239-1241. PubMed ID: 35699869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Windecker S; Tijssen J; Giustino G; Guimarães AH; Mehran R; Valgimigli M; Vranckx P; Welsh RC; Baber U; van Es GA; Wildgoose P; Volkl AA; Zazula A; Thomitzek K; Hemmrich M; Dangas GD
    Am Heart J; 2017 Feb; 184():81-87. PubMed ID: 27892890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial.
    Giustino G; Tijssen J; Windecker S; Dangas G
    Cardiovasc Res; 2020 Mar; 116(3):e39-e41. PubMed ID: 32077477
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
    De Backer O; Dangas GD; Jilaihawi H; Leipsic JA; Terkelsen CJ; Makkar R; Kini AS; Veien KT; Abdel-Wahab M; Kim WK; Balan P; Van Mieghem N; Mathiassen ON; Jeger RV; Arnold M; Mehran R; Guimarães AHC; Nørgaard BL; Kofoed KF; Blanke P; Windecker S; Søndergaard L;
    N Engl J Med; 2020 Jan; 382(2):130-139. PubMed ID: 31733182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    Dangas GD; Tijssen JGP; Wöhrle J; Søndergaard L; Gilard M; Möllmann H; Makkar RR; Herrmann HC; Giustino G; Baldus S; De Backer O; Guimarães AHC; Gullestad L; Kini A; von Lewinski D; Mack M; Moreno R; Schäfer U; Seeger J; Tchétché D; Thomitzek K; Valgimigli M; Vranckx P; Welsh RC; Wildgoose P; Volkl AA; Zazula A; van Amsterdam RGM; Mehran R; Windecker S;
    N Engl J Med; 2020 Jan; 382(2):120-129. PubMed ID: 31733180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
    Sherwood MW; Vora AN
    Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
    Capodanno D; Collet JP; Dangas G; Montalescot G; Ten Berg JM; Windecker S; Angiolillo DJ
    JACC Cardiovasc Interv; 2021 Aug; 14(15):1688-1703. PubMed ID: 34353601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis.
    Holy EW; Kebernik J; Allali A; El-Mawardy M; Richardt G; Abdel-Wahab M
    Cardiol J; 2017; 24(6):649-659. PubMed ID: 28497845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial.
    Park DW; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Yun SC; Lee SA; Ko E; Park H; Kim DH; Kang JW; Lee JH; Park SJ;
    Circulation; 2022 Aug; 146(6):466-479. PubMed ID: 35373583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Outcomes After Transcatheter Aortic Valve Replacement: A POPular TAVI Subanalysis.
    van Bergeijk KH; van Ginkel DJ; Brouwer J; Nijenhuis VJ; van der Werf HW; van den Heuvel AFM; Voors AA; Wykrzykowska JJ; Ten Berg JM
    JACC Cardiovasc Interv; 2023 May; 16(9):1095-1102. PubMed ID: 37164609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
    Kobari Y; Inohara T; Saito T; Yoshijima N; Tanaka M; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    Circ Cardiovasc Interv; 2021 May; 14(5):e010097. PubMed ID: 34003663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement.
    Park H; Kang DY; Ahn JM; Kim KW; Wong AYT; Lam SCC; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Kim DH; Koo HJ; Yang DH; Kang JW; Jung SC; Lee JH; Yun SC; Park SJ; Park DW
    BMJ Open; 2021 Jan; 11(1):e042587. PubMed ID: 33402409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy.
    Montalescot G; Redheuil A; Vincent F; Desch S; De Benedictis M; Eltchaninoff H; Trenk D; Serfaty JM; Charpentier E; Bouazizi K; Prigent M; Guedeney P; Salloum T; Berti S; Cequier A; Lefèvre T; Leprince P; Silvain J; Van Belle E; Neumann FJ; Portal JJ; Vicaut E; Collet JP;
    JACC Cardiovasc Interv; 2022 Sep; 15(18):1794-1804. PubMed ID: 36137682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy after transcatheter aortic valve replacement: current perspective.
    Eckstein J; Liu S; Toleva O; Yanagawa B; Verma S; Cheema AN
    Curr Opin Cardiol; 2021 Mar; 36(2):117-124. PubMed ID: 33394711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
    Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM
    Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial.
    Collet JP; Berti S; Cequier A; Van Belle E; Lefevre T; Leprince P; Neumann FJ; Vicaut E; Montalescot G
    Am Heart J; 2018 Jun; 200():44-50. PubMed ID: 29898848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
    van Ginkel DJ; Bor WL; Veenstra L; van 't Hof AWJ; Fabris E
    Eur J Intern Med; 2022 Jul; 101():14-20. PubMed ID: 35623935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
    Huchet F; Letocart V; Guerin P; Cueff C; Roy-Giocosa J; Guyomarch-Delasalle B; Jaafar P; Manigold T
    Arch Cardiovasc Dis; 2018 Jan; 111(1):25-32. PubMed ID: 28943264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.